Ireland· IE-PA-PA1226/001/005
Distaclor LA Forte 500 mg prolonged-release tablets
A cefaclor product containing cefaclor monohydrate, registered in Ireland by Flynn Pharma Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Cefaclor is registered in 11 of 19 countries.
Countries holding a registration under ATC J01DC04 (cefaclor), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Cefaclor · ATC J01DC04
11 / 19 countries
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefaclor costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $1.23 in Spain to $2.73 in France — a ×2.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefaclor · price per daily dose (1 g)
USD · FX 28 Sept 2026
- FR France$2.73
- IT Italy$2.32
- ES Spain$1.23
The record
At a glance
HPRA (Ireland)- Active substance
- Cefaclor monohydrate
- Manufacturer
- Flynn Pharma Limited
- Country
- Ireland (IE)
- ATC code
- J01DC04
- ATC class
- Cefaclor
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1226/001/005
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
102 interactions on record for cefaclor.
Graded by severity as the source publishes them — 18 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefaclor · interactions on record
102 records
- 18 moderate
- 84 info
Most severe, free to view
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Sodium picosulfateA06AB08moderate
- Magnesium oxideA06AD02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefaclor in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandKefolorEli Lilly Italia S.p.A.
- United KingdomBacticlor MR 375mg tabletsSun Pharma UK Ltd
- ItalyBACTIGRAMAESCULAPIUS FARMACEUTICI S.R.L.
- GermanyCefaclor1 A Pharma Gmbh
- Japanセファクロル長生堂製薬
- PolandCeclorTeva Pharmaceuticals Polska Sp. z o.o.
- United StatesCefaclorA-S Medication Solutions
- FranceALFATIL 125 mg/5 ml, poudre pour suspension buvableLABORATOIRES ETHYPHARM
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Ceclor, Ceclor Forte
- Bulgaria · Медоклор, Цефаклор Алкалоид
- Cyprus · C E C L O R Mr, Ceclor
- Germany · Cefaclor, Cefaclor Al
- France · Alfatil, Alfatil Lp
- United Kingdom (Northern Ireland) · Cefaclor, Cefaclor Clydesdale Pharma
- Greece · Ceclor, Ceclor Mr
- Hungary · Ceclor, Ceclor Forte
- Italy · Bactigram, Cefaclor Eg
- Malta · Ceclor
- Netherlands · Cefaclor Sandoz
- Poland · Ceclor, Ceclor Mr
- Portugal · Ceclor, Ceclor Retard
- Romania · Ceclor, Cefaclor Arena
- Slovenia · Ceclor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6b5e853a-8e9c-4f47-9d9f-c5bd32c26637 GET /v1/drugs/6b5e853a-8e9c-4f47-9d9f-c5bd32c26637?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prolonged-release tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J01DC",
"J01DC04"
],
"strength": null,
"pa_number": "PA1226/001/005",
"substances": [
"Cefaclor monohydrate"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "16/06/1994",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about cefaclor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.